{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:42:52Z","timestamp":1770522172617,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001234","name":"Royal Australian College of General Practitioners","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001234","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.sapharm.2023.01.011","type":"journal-article","created":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T09:56:24Z","timestamp":1674986184000},"page":"836-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cluster-randomised trial of the Effectiveness of Quality Incentive Payments in General Practice (EQuIP-GP): Prescribing of medicines outcomes"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-3882","authenticated-orcid":false,"given":"Gregory M.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Radford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Zwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijka","family":"Batterham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Eckermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Metusela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Saunder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Kitsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bonney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.01.011_bib1","series-title":"Chronic failure in primary medical care","isbn-type":"print","author":"Swerissen","year":"2016","ISBN":"https:\/\/id.crossref.org\/isbn\/9781925015805"},{"key":"10.1016\/j.sapharm.2023.01.011_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1071\/PY20095","article-title":"What should primary care look like after the COVID-19 pandemic?","volume":"26","author":"Duckett","year":"2020","journal-title":"Aust J Prim Health"},{"key":"10.1016\/j.sapharm.2023.01.011_bib3","series-title":"Health Economics from Theory to Practice: Optimally Informing Joint Decisions of Research, Reimbursement and Regulation with Health System Budget Constraints and Community Objectives","author":"Eckermann","year":"2017"},{"key":"10.1016\/j.sapharm.2023.01.011_bib4","first-page":"1","article-title":"Effectiveness of quality incentive payments in general practice (EQuIP-GP): a study protocol for a cluster-randomised trial of an outcomes-based funding model in Australian general practice to improve patient care","volume":"2","author":"Peterson","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2023.01.011_bib5","article-title":"Effectiveness of Quality Incentive Payments in General Practice (EQuIP-GP) cluster randomized trial: impact on patient-reported experience","author":"Bonney","year":"2021","journal-title":"Fam Pract"},{"key":"10.1016\/j.sapharm.2023.01.011_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1370\/afm.2359","article-title":"Identifying adverse drug events in older community-dwelling patients","volume":"17","author":"Cahir","year":"2019","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.sapharm.2023.01.011_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymeth.2016.07.023","article-title":"Improving drug safety: from adverse drug reaction knowledge discovery to clinical implementation","volume":"110","author":"Tan","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.sapharm.2023.01.011_bib9","doi-asserted-by":"crossref","first-page":"l4185","DOI":"10.1136\/bmj.l4185","article-title":"Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis","volume":"366","author":"Panagioti","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2023.01.011_bib10","unstructured":"Roughead L., Semple S., Rosenfeld E. Literature review: medication safety in Australia. Australian Commission on Safety and Quality in Health Care. 2013. [Available from: https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/migrated\/Literature-Review-Medication-Safety-in-Australia-2013.pdf. [Accessed 4 May 2022]."},{"key":"10.1016\/j.sapharm.2023.01.011_bib11","series-title":"Medicine Safety: Take Care","author":"Pharmaceutical Society of Australia","year":"2019"},{"key":"10.1016\/j.sapharm.2023.01.011_bib12","series-title":"Quality use of medicines and medicines safety (10th national health priority). Discussion paper for public consultation \u2013 phase 1: aged care","year":"2020"},{"key":"10.1016\/j.sapharm.2023.01.011_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations - the elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2023.01.011_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.sapharm.2023.01.011_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2023.01.011_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2165\/11319530-000000000-00000","article-title":"Polypharmacy status as an indicator of mortality in an elderly population","volume":"26","author":"Jyrkk\u00e4","year":"2009","journal-title":"Drugs Aging"},{"issue":"67","key":"10.1016\/j.sapharm.2023.01.011_bib17","first-page":"674","article-title":"Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"2109","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2023.01.011_bib19","article-title":"Evaluation of the health care Homes program","volume":"2","year":"2020","journal-title":"Interim evaluation report"},{"key":"10.1016\/j.sapharm.2023.01.011_bib20","series-title":"Census of population and housing: socio-economic Indexes for Areas (SEIFA), Australia (cat. No. 2033.0.55.001)","author":"Australian Bureau of Statistics","year":"2016"},{"key":"10.1016\/j.sapharm.2023.01.011_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","article-title":"Health-related quality of life measured using the EQ-5D-5L: south Australian population norms","volume":"14","author":"McCaffrey","year":"2016","journal-title":"Health Qual Life Outcome"},{"issue":"1","key":"10.1016\/j.sapharm.2023.01.011_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12877-020-01766-7","article-title":"Barriers to effective prescribing in older adults: applying the theoretical domains framework in the ambulatory setting - a scoping review","volume":"20","author":"Lau","year":"2020","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.sapharm.2023.01.011_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12909-019-1735-3","article-title":"Changing prescribing behaviours with educational outreach: an overview of evidence and practice","volume":"19","author":"Kunstler","year":"2019","journal-title":"BMC Med Educ"},{"issue":"10","key":"10.1016\/j.sapharm.2023.01.011_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258674","article-title":"General practice pharmacists in Australia: a systematic review","volume":"16","author":"Sudeshika","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2023.01.011_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MLR.0000000000000042","article-title":"Effects of continuity of care on medication duplication among the elderly","volume":"52","author":"Cheng","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2023.01.011_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijporl.2019.109616","article-title":"The impact of continuity of care on antibiotic prescribing in acute otitis media","volume":"126","author":"Barrera","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.sapharm.2023.01.011_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1370\/afm.63","article-title":"Continuity of primary care: to whom does it matter and when?","volume":"1","author":"Nutting","year":"2003","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.sapharm.2023.01.011_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/14739879.2012.11494102","article-title":"The older patient, the general practitioner and the trainee: patients' attitudes and implications for training","volume":"23","author":"Bonney","year":"2012","journal-title":"Educ Prim Care"},{"key":"10.1016\/j.sapharm.2023.01.011_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/fampra\/cml010","article-title":"\u2018Two sides of the coin\u2019 - the value of personal continuity to GPs: a qualitative interview study","volume":"23","author":"Ridd","year":"2006","journal-title":"Fam Pract"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:29:36Z","timestamp":1761557376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1551741123000311"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.01.011","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cluster-randomised trial of the Effectiveness of Quality Incentive Payments in General Practice (EQuIP-GP): Prescribing of medicines outcomes","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}